Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
version: 14; Last updated: 2023-12-06 17:44:57+0000
Profiles: ComparativeEvidence, SingleStudyEvidence
url: https://fevir.net/resources/Evidence/47665
identifier: FEvIR Object Identifier/47665
name: ComparativeEvidence_Mean_difference_in_HbA1c_between_Surgery_and_Medical_Lifestyle_groups_in_Mingrone_2012_DIBASY_trial
title: ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Mingrone 2012 (DIBASY) trial
status: Active
date: 2022-05-29 11:06:42+0000
author: Brian S. Alper:
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
| Code | Value[x] |
| Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | ComparativeEvidence |
| Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | SingleStudyEvidence |
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
relatesTo
type: Derived From
relatesTo
type: Cite As
target:
ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Mingrone 2012 (DIBASY) trial [Evidence]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 47665. Revised 2022-05-29. Available at: https://fevir.net/resources/Evidence/47665. Computable resource at: https://fevir.net/resources/Evidence/47665.
description:
Mean HbA1c at 24 months in Mingrone 2012 was 5.65% in Surgery group (n = 20) and 7.69% in Medical/Lifestyle group (n = 20), mean difference -2.04% (95% CI -2.53% to -1.55%)
variableDefinition
description:
60 patients aged 30-60 years with a body-mass index of 35 kg/m(2) or more and a history of type 2 diabetes lasting at least 5 years
variableRole: Population
observed: DIBASY Trial Enrollment Group
variableDefinition
description:
Roux-en-Y gastric bypass vs. medical treatment
variableRole: Exposure
comparatorCategory: medical treatment
observed: GroupAssignment: Roux-en-Y gastric bypass vs. medical treatment
variableDefinition
description:
HbA1c at 24 months
variableRole: Outcome
observed: OutcomeVariable: HbA1c at 24 months
synthesisType: not applicable
studyDesign: randomized assignment
statistic
description:
mean difference -2.04% (95% CI -2.53% to -1.55%)
note:
Mean HbA1c at 24 months in Mingrone 2012 was 5.65% in Surgery group (n = 20) and 7.69% in Medical/Lifestyle group (n = 20)
statisticType: Mean Difference
quantity: -2.04 % (Details: UCUM code% = '%')
SampleSizes
NumberOfParticipants KnownDataCount 40 40 AttributeEstimates
Description Type Level Range 95% CI -2.53% to -1.55%
Confidence interval 0.95 -2.53--1.55 %
IG © 2024+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot2 based on FHIR 6.0.0-ballot3. Generated 2025-08-21
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change